NCT00064363View on ClinicalTrials.gov

Talampanel in Treating Patients With Recurrent High-Grade Glioma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2003

Study Completion Date

February 28, 2007

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

talampanel

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00064363 - Talampanel in Treating Patients With Recurrent High-Grade Glioma | Biotech Hunter | Biotech Hunter